IL131701A - Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents - Google Patents

Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents

Info

Publication number
IL131701A
IL131701A IL13170198A IL13170198A IL131701A IL 131701 A IL131701 A IL 131701A IL 13170198 A IL13170198 A IL 13170198A IL 13170198 A IL13170198 A IL 13170198A IL 131701 A IL131701 A IL 131701A
Authority
IL
Israel
Prior art keywords
compositions
shark cartilage
neoplastic agents
treating tumors
tumors containing
Prior art date
Application number
IL13170198A
Other languages
English (en)
Other versions
IL131701A0 (en
Original Assignee
Aeterna Zentaris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Inc filed Critical Aeterna Zentaris Inc
Publication of IL131701A0 publication Critical patent/IL131701A0/xx
Publication of IL131701A publication Critical patent/IL131701A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13170198A 1997-03-11 1998-03-11 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents IL131701A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2199694 1997-03-11
PCT/CA1998/000202 WO1998040088A1 (en) 1997-03-11 1998-03-11 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents

Publications (2)

Publication Number Publication Date
IL131701A0 IL131701A0 (en) 2001-03-19
IL131701A true IL131701A (en) 2005-03-20

Family

ID=4160148

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13170198A IL131701A (en) 1997-03-11 1998-03-11 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents

Country Status (18)

Country Link
US (2) US6383522B1 (de)
EP (1) EP0967987B1 (de)
JP (1) JP2001500899A (de)
KR (1) KR100417612B1 (de)
CN (2) CN1245993C (de)
AT (1) ATE241993T1 (de)
AU (1) AU745769B2 (de)
BR (1) BR9808858A (de)
CA (1) CA2281570C (de)
DE (1) DE69815310T2 (de)
DK (1) DK0967987T3 (de)
ES (1) ES2200316T3 (de)
IL (1) IL131701A (de)
NO (1) NO322847B1 (de)
NZ (1) NZ337376A (de)
PT (1) PT967987E (de)
RU (1) RU2195946C2 (de)
WO (1) WO1998040088A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
CA2461227C (en) * 2001-09-24 2012-05-15 Jessie L.-S Au Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20070010430A1 (en) * 2003-03-20 2007-01-11 Hosokawa Micron Corparation Proteoglycan isolated from cartilaginous fish and process for producing the same
DE04777189T1 (de) * 2003-07-02 2011-04-07 Solux Corporation, San Diego Thermisch stabiles kristallines epirubicin-hydrochlorid und herstellungsverfahren dafür
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
EP2295080A3 (de) 2005-07-25 2011-06-22 Emergent Product Development Seattle, LLC B-Zell-Verringerung mit CD37-spezifischen und CD20-spezifischen Bindungsmolekülen
EP1930017B1 (de) 2005-09-29 2012-05-23 Maruha Nichiro Seafoods, Inc. Zusammensetzung zur prävention und behandlung von krankheiten von erwachsenen
CN105837690A (zh) 2006-06-12 2016-08-10 新兴产品开发西雅图有限公司 具有效应功能的单链多价结合蛋白
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
CN101990439A (zh) * 2007-07-06 2011-03-23 特鲁比昂药品公司 具有置于c末端的特异性结合结构域的结合肽
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
PT2132228E (pt) * 2008-04-11 2011-10-11 Emergent Product Dev Seattle Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
KR102784293B1 (ko) 2015-09-21 2025-03-20 압테보 리서치 앤드 디벨롭먼트 엘엘씨 Cd3 결합 폴리펩타이드
WO2017201200A1 (en) * 2016-05-19 2017-11-23 Orphagen Pharmaceuticals, Inc. Therapeutic compositions containing rar-alpha antagonists

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28093E (en) 1962-02-28 1974-07-30 Wound-healing cartilage powder
US3478146A (en) 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3966908A (en) 1973-11-29 1976-06-29 Lescarden Ltd. Method of treating degenerative joint afflictions
US4042457A (en) 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4822607A (en) * 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4212857A (en) 1976-10-29 1980-07-15 Lescarden Ltd. Method for stimulating the production of immunoglobulin and total complement
US4243582A (en) 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4456589A (en) 1982-07-08 1984-06-26 Genetic Laboratories, Inc. Preparation of animal tissues for surgical implantation in human recipients
US4473551A (en) 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
JPS5939828A (ja) 1982-08-28 1984-03-05 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4444752A (en) 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4469676A (en) 1983-06-21 1984-09-04 Michel Hecmati Method for eliminating wrinkles occurring in the human skin
JPS60178820A (ja) 1984-02-22 1985-09-12 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4656137A (en) 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
US5096892A (en) 1988-05-27 1992-03-17 The Children's Medical Center Corporation Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin
ES2093699T3 (es) * 1990-01-25 1997-01-01 Childrens Hosp Medical Center Metodo y composiciones para inhibir la angiogenesis.
US5075112A (en) 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
EP0571597A4 (en) 1991-11-15 1994-06-01 Arthro Res & Dev Corp Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals
WO1994012510A1 (en) 1992-11-30 1994-06-09 Lane I William Processing shark cartilage
CN1502331A (zh) 1993-07-19 2004-06-09 Ѫ�ܼ���ҩ�﹫˾ 抗血管生长组合物及使用方法
US6025334A (en) 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5618925A (en) 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6028118A (en) 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
RU2066181C1 (ru) * 1994-06-02 1996-09-10 Онкологический научный центр им. Н.Н.Блохина Противоопухолевое средство
US5583153A (en) 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
RU2157695C2 (ru) * 1995-02-03 2000-10-20 Ле Лабораториз Аетерна Инк. Экстракты хрящей акулы, способ их получения и применения
US5843920A (en) 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof

Also Published As

Publication number Publication date
AU6605598A (en) 1998-09-29
CN1245993C (zh) 2006-03-22
CN1250375A (zh) 2000-04-12
US20020146462A1 (en) 2002-10-10
CA2281570A1 (en) 1998-09-17
US6855338B2 (en) 2005-02-15
JP2001500899A (ja) 2001-01-23
IL131701A0 (en) 2001-03-19
BR9808858A (pt) 2000-08-01
ATE241993T1 (de) 2003-06-15
HK1026364A1 (en) 2000-12-15
EP0967987B1 (de) 2003-06-04
RU2195946C2 (ru) 2003-01-10
KR20000075929A (ko) 2000-12-26
AU745769B2 (en) 2002-03-28
ES2200316T3 (es) 2004-03-01
US6383522B1 (en) 2002-05-07
NO994274L (no) 1999-11-09
WO1998040088A1 (en) 1998-09-17
DE69815310T2 (de) 2004-04-22
DE69815310D1 (de) 2003-07-10
DK0967987T3 (da) 2003-09-22
CN1824317A (zh) 2006-08-30
NO322847B1 (no) 2006-12-11
EP0967987A1 (de) 2000-01-05
CA2281570C (en) 2003-09-23
KR100417612B1 (ko) 2004-02-05
NO994274D0 (no) 1999-09-02
PT967987E (pt) 2003-10-31
NZ337376A (en) 2002-02-01

Similar Documents

Publication Publication Date Title
IL131701A0 (en) Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
AP9700952A0 (en) Antineoplastic cocoa extracts and method for making and using the same.
WO2002076499A3 (en) Combination treatment of pancreatic cancer
PL343593A1 (en) Use of cabergoline in the treatment of restless legs syndrome
SG148031A1 (en) Use of cci-779 as an antineoplastic agent
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
IL141686A0 (en) Methods of treating hypertension and compositions for use therein
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
ZA988461B (en) Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
IL128610A0 (en) Cryptophycin compounds
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
MY129632A (en) Wood preservative formulations
MXPA04005942A (es) Composiciones y metodos de sintaxina 3.
IL131478A0 (en) Methods for treatment of scar tissue
BG104914A (en) Paroxetine maleate
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
MXPA03002494A (es) Metodo para reducir toxicidad de quimio terapias combinadas.
GB9723824D0 (en) Cytostatic agents
PL365075A1 (en) Combinations of dalfopristine/quinupristine with cefpirome
MX9710304A (es) Composiciones para la preparacion de cuero.
IT1271292B (it) Composizioni farmaceutiche contenenti melatonina e inibitori dei recettori degli estrogeni
MX9706183A (es) Analogos de paclitaxel, preparaciones y uso como agentes antitumorales.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed